Fatal family insomnia’s prevalence index and main initial clinical manifestations

Detalhes bibliográficos
Autor(a) principal: Lustosa, Natalia Giffoni
Data de Publicação: 2021
Outros Autores: Santos, Lucas Brito dos, Sousa, Vanessa Alves de, Silva, Áthila Gabriele Ferreira da, Rodrigues, Cicera Natália da Silva, Duarte, Gema Galgani de Mesquita, Soares, Evelise Aline
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/21719
Resumo: Introduction: Fatal familial insomnia (FFI) is a neurodegenerative autosomal dominant prion disease caused by a mutation in the cellular protein gene (PrPC). The aim of this review is to identify the initial clinical manifestations of FFI and its geographic distribution during the last decade. Methodology: This is a systematic literature review which includes case reports about FFI, published from 2011 to 2021, indexed in PubMed/MEDLINE databases. Results: Forty-nine individuals with FFI were detected. The most common initial symptoms were progressive insomnia (55%), cognitive deficits (25%), weight loss (25%), gait alterations (25%) and disorientation (25%). Some cases presented symptoms suggestive of other diagnostic hypotheses such as tremors (15%) and mood changes (10%). The USA presented an absolute frequency of 17 people distributed in three families. China had a total of ten affected by FFI in five families. Brazil, Germany and South Korea had two affected families each country. However, regarding the total number of FFI carriers, Brazil had seven, but South Korea, France and Spain had three carriers each country. Conclusion: China and the USA have the highest FFI absolute frequencies, yet some European countries, such as Spain and France, have a higher relative frequency. Although insomnia is the most common initial symptom, there are cases which FFI may initially manifest with symptoms that mimic other neurodegenerative pathologies or psychological pathologies, difficulting the diagnosis.
id UNIFEI_eaa84113d048f8805c5185f284e1fe40
oai_identifier_str oai:ojs.pkp.sfu.ca:article/21719
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Fatal family insomnia’s prevalence index and main initial clinical manifestationsÍndice de prevalencia y principales manifestaciones clínicas iniciales del insomnio fatal familiarÍndice de prevalência e principais manifestações clínicas iniciais da insônia familiar fatalFatal Familial InsomniaHereditary Prion DiseaseClinical FeaturesEpidemiology.Insomnio Familiar FatalEnfermedad Priónica HereditariaCaracterísticas ClínicasEpidemiología.Insônia Familiar FatalDoença Priônica HereditáriaCaracterísticas ClínicasEpidemiologia.Introduction: Fatal familial insomnia (FFI) is a neurodegenerative autosomal dominant prion disease caused by a mutation in the cellular protein gene (PrPC). The aim of this review is to identify the initial clinical manifestations of FFI and its geographic distribution during the last decade. Methodology: This is a systematic literature review which includes case reports about FFI, published from 2011 to 2021, indexed in PubMed/MEDLINE databases. Results: Forty-nine individuals with FFI were detected. The most common initial symptoms were progressive insomnia (55%), cognitive deficits (25%), weight loss (25%), gait alterations (25%) and disorientation (25%). Some cases presented symptoms suggestive of other diagnostic hypotheses such as tremors (15%) and mood changes (10%). The USA presented an absolute frequency of 17 people distributed in three families. China had a total of ten affected by FFI in five families. Brazil, Germany and South Korea had two affected families each country. However, regarding the total number of FFI carriers, Brazil had seven, but South Korea, France and Spain had three carriers each country. Conclusion: China and the USA have the highest FFI absolute frequencies, yet some European countries, such as Spain and France, have a higher relative frequency. Although insomnia is the most common initial symptom, there are cases which FFI may initially manifest with symptoms that mimic other neurodegenerative pathologies or psychological pathologies, difficulting the diagnosis.Introducción: El insomnio familiar fatal (IFF) es una enfermedad priónica autosómica dominante y neurodegenerativa causada por una mutación en el gen de la proteína priónica celular (PrPC). El objetivo de esta revisión es identificar las manifestaciones clínicas iniciales de la IFF y su distribución geográfica durante la última década. Metodología: Se trata de una revisión sistemática de la literatura que incluye informes de casos sobre el IFF, publicados de 2011 a 2021, indexados en la base de datos PubMed / MEDLINE. Resultados: se detectaron 49 individuos con IFF. Los síntomas iniciales más comunes fueron insomnio progresivo (55%), déficits cognitivos (25%), pérdida de peso (25%), alteraciones de la marcha (25%) y desorientación (25%). Algunos casos presentaron síntomas sugestivos de otras hipótesis diagnósticas como temblores (15%) y alteraciones del estado de ánimo (10%). Los EUA tuvo una frecuencia absoluta de 17 personas distribuidas en tres familias. China tenía un total de diez afectados por IFF distribuidos en cinco familias. Brasil, Alemania y Corea del Sur tenían dos familias afectadas cada uno. Sin embargo, con respecto al número total de operadores IFF, Brasil tenía siete y Corea del Sur, Francia y España, tres operadores cada uno. Conclusión: China y EUA tienen las frecuencias absolutas más altas de IFF, sin embargo, algunos países europeos, como España y Francia, tienen una frecuencia relativa más alta. Si bien el insomnio es el síntoma inicial más común, existen casos en los que los síntomas iniciales imitan otras patologías neurodegenerativas o patologías psicológicas, lo que dificulta el diagnóstico.Introdução: A insônia familiar fatal (IFF) é uma doença priônica autossômica dominante e neurodegenerativa causada por uma mutação no gene da proteína príon celular (PrPC). O objeivo dessa revisão é identificar as manifestações clínicas iniciais da IFF e sua distribuição geográfica durante a última década. Metodologia: Trata-se de uma revisão sistemática da literatura incluindo  relatos de casos sobre a IFF, publicados no período de 2011 a 2021, indexados na base de dados do PubMed/MEDLINE. Resultados: Foram detectados 49 indivíduos portadores de IFF. Os sintomas iniciais mais comuns foram insônia progressiva (55%), déficits cognitivos (25%), redução ponderal (25%), alterações da marcha (25%) e desorientação (25%). Alguns casos apresentaram sintomas sugestivos de outras hipóteses diagnósticas como tremores (15%) e alterações do humor (10%). Os EUA apresentaram frequência absoluta de 17 pessoas distribuídas em três famílias. A China teve um total de dez afetados por IFF distribuídos em cinco famílias. Brasil, Alemanha e Coreia do Sul apresentaram duas famílias afetadas cada. Porém, quanto ao total de portadores de IFF, Brasil apresentou sete e Coreia do Sul, França e Espanha, três portadores cada. Conclusão: a China e o EUA apresentam as maiores frequências absolutas de IFF, contudo, alguns países europeus, como Espanha e França, possuem uma frequência relativa maior. Apesar de a insônia ser o sintoma inicial mais comum, existem casos nos quais a IFF pode se manifestar inicialmente com sintomas que mimetizam outras patologias neurodegenerativas ou patologias de ordem psicológica, dificultando o diagnóstico.Research, Society and Development2021-10-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2171910.33448/rsd-v10i14.21719Research, Society and Development; Vol. 10 No. 14; e168101421719Research, Society and Development; Vol. 10 Núm. 14; e168101421719Research, Society and Development; v. 10 n. 14; e1681014217192525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/21719/19463Copyright (c) 2021 Natalia Giffoni Lustosa; Lucas Brito dos Santos; Vanessa Alves de Sousa; Áthila Gabriele Ferreira da Silva; Cicera Natália da Silva Rodrigues; Gema Galgani de Mesquita Duarte; Evelise Aline Soareshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLustosa, Natalia GiffoniSantos, Lucas Brito dosSousa, Vanessa Alves deSilva, Áthila Gabriele Ferreira daRodrigues, Cicera Natália da SilvaDuarte, Gema Galgani de MesquitaSoares, Evelise Aline2021-12-04T11:48:39Zoai:ojs.pkp.sfu.ca:article/21719Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:41:04.618992Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Fatal family insomnia’s prevalence index and main initial clinical manifestations
Índice de prevalencia y principales manifestaciones clínicas iniciales del insomnio fatal familiar
Índice de prevalência e principais manifestações clínicas iniciais da insônia familiar fatal
title Fatal family insomnia’s prevalence index and main initial clinical manifestations
spellingShingle Fatal family insomnia’s prevalence index and main initial clinical manifestations
Lustosa, Natalia Giffoni
Fatal Familial Insomnia
Hereditary Prion Disease
Clinical Features
Epidemiology.
Insomnio Familiar Fatal
Enfermedad Priónica Hereditaria
Características Clínicas
Epidemiología.
Insônia Familiar Fatal
Doença Priônica Hereditária
Características Clínicas
Epidemiologia.
title_short Fatal family insomnia’s prevalence index and main initial clinical manifestations
title_full Fatal family insomnia’s prevalence index and main initial clinical manifestations
title_fullStr Fatal family insomnia’s prevalence index and main initial clinical manifestations
title_full_unstemmed Fatal family insomnia’s prevalence index and main initial clinical manifestations
title_sort Fatal family insomnia’s prevalence index and main initial clinical manifestations
author Lustosa, Natalia Giffoni
author_facet Lustosa, Natalia Giffoni
Santos, Lucas Brito dos
Sousa, Vanessa Alves de
Silva, Áthila Gabriele Ferreira da
Rodrigues, Cicera Natália da Silva
Duarte, Gema Galgani de Mesquita
Soares, Evelise Aline
author_role author
author2 Santos, Lucas Brito dos
Sousa, Vanessa Alves de
Silva, Áthila Gabriele Ferreira da
Rodrigues, Cicera Natália da Silva
Duarte, Gema Galgani de Mesquita
Soares, Evelise Aline
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Lustosa, Natalia Giffoni
Santos, Lucas Brito dos
Sousa, Vanessa Alves de
Silva, Áthila Gabriele Ferreira da
Rodrigues, Cicera Natália da Silva
Duarte, Gema Galgani de Mesquita
Soares, Evelise Aline
dc.subject.por.fl_str_mv Fatal Familial Insomnia
Hereditary Prion Disease
Clinical Features
Epidemiology.
Insomnio Familiar Fatal
Enfermedad Priónica Hereditaria
Características Clínicas
Epidemiología.
Insônia Familiar Fatal
Doença Priônica Hereditária
Características Clínicas
Epidemiologia.
topic Fatal Familial Insomnia
Hereditary Prion Disease
Clinical Features
Epidemiology.
Insomnio Familiar Fatal
Enfermedad Priónica Hereditaria
Características Clínicas
Epidemiología.
Insônia Familiar Fatal
Doença Priônica Hereditária
Características Clínicas
Epidemiologia.
description Introduction: Fatal familial insomnia (FFI) is a neurodegenerative autosomal dominant prion disease caused by a mutation in the cellular protein gene (PrPC). The aim of this review is to identify the initial clinical manifestations of FFI and its geographic distribution during the last decade. Methodology: This is a systematic literature review which includes case reports about FFI, published from 2011 to 2021, indexed in PubMed/MEDLINE databases. Results: Forty-nine individuals with FFI were detected. The most common initial symptoms were progressive insomnia (55%), cognitive deficits (25%), weight loss (25%), gait alterations (25%) and disorientation (25%). Some cases presented symptoms suggestive of other diagnostic hypotheses such as tremors (15%) and mood changes (10%). The USA presented an absolute frequency of 17 people distributed in three families. China had a total of ten affected by FFI in five families. Brazil, Germany and South Korea had two affected families each country. However, regarding the total number of FFI carriers, Brazil had seven, but South Korea, France and Spain had three carriers each country. Conclusion: China and the USA have the highest FFI absolute frequencies, yet some European countries, such as Spain and France, have a higher relative frequency. Although insomnia is the most common initial symptom, there are cases which FFI may initially manifest with symptoms that mimic other neurodegenerative pathologies or psychological pathologies, difficulting the diagnosis.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/21719
10.33448/rsd-v10i14.21719
url https://rsdjournal.org/index.php/rsd/article/view/21719
identifier_str_mv 10.33448/rsd-v10i14.21719
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/21719/19463
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 14; e168101421719
Research, Society and Development; Vol. 10 Núm. 14; e168101421719
Research, Society and Development; v. 10 n. 14; e168101421719
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052757390131200